Status:
COMPLETED
Abnormal Uterine Bleeding and Progestin-only Contraceptives
Lead Sponsor:
Assiut University
Conditions:
Contraception
Eligibility:
FEMALE
18-40 years
Brief Summary
The use of progestin-only methods of contraception has been increased obviously and progressively over the world in the last few years. Progestin-only contraception is an option for women in whom an e...
Eligibility Criteria
Inclusion
- Women aged between 18-40 years.
- Women with more than 12 month postpartum.
- Women who had normal menstrual pattern (cycle from 21 - 35 days with a same cycle length variation of no more than 5 days, bleeding days from 2-7 days and number of sanitary pads not more than 3 pads without blood clots or flooding of blood).
- Women wanted to use DMPA, etonogestrel subdermal implant or POPs only for pregnancy prevention for at least 1 year.
Exclusion
- Women on any anticoagulant therapy.
- Women who had a history of uterine, cervical or ovarian pathology.
- Women who had uterine bleeding disturbance (including amenorrhea) before recruitment.
- Women received DMPA injection within the previous 9 months except they had three spontaneous regular menstrual cycles.
- Severely anemic women (hemoglobin \< 8gm/dl).
- Women with any contraindications for POCs following the WHO eligibility (Altshuler AL et al., 2015).
- Women refused to participate in the study.
Key Trial Info
Start Date :
August 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2020
Estimated Enrollment :
390 Patients enrolled
Trial Details
Trial ID
NCT03398811
Start Date
August 1 2018
End Date
November 1 2020
Last Update
December 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Women Health Hospital - Assiut university
Asyut, Egypt, 71111